Personalized low-volume blood pressure care during laparoscopic liver surgery
Part of Cancer, Digestive system clinical trials.
This study looks at a customized blood-pressure and fluid strategy to help patients during laparoscopic liver tumor removal. It may help reduce complications related to blood loss and organ stress during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of hepatocellular carcinoma (liver cancer).
- You plan to have laparoscopic hepatectomy (keyhole liver surgery) and agree to join.
- You are at least 18 years old.
- You are not pregnant.
- You can and are willing to receive blood transfusions if needed.
- Your heart, lungs, blood counts, kidneys, liver numbers, and clotting must be stable enough for surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a specific salt-water fluid (sodium bicarbonate in Ringer’s solution) during laparoscopic liver surgery can improve safety or outcomes. You may be eligible if you’re an adult planning this type of minimally invasive liver operation and can provide consent.
This study tests ways to reduce the need for blood transfusions during major liver surgery. Researchers will track patients undergoing large liver resections to see if new blood-management techniques can help you need fewer transfusions while staying safe.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial tests whether using stroke volume variation (SVV) is better than central venous pressure (CVP) to guide fluid management and reduce bleeding during open liver surgery. It aims to find a safer way to manage fluids during the operation.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This study tests whether personalized blood pressure management during and after major surgery can reduce complications and death in older adults with heart or blood vessel risks. It aims to find the safest blood pressure targets for each patient.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.